⌘K

Home/Filings/4/0001048477-25-000060

4//SEC Filing

Burkhart Erin 4

Accession 0001048477-25-000060

CIK 0001048477other

View on SEC.gov Company Profile

Filed

May 19, 8:00 PM ET

Accepted

May 20, 5:58 PM ET

Size

6.0 KB

Accession

0001048477-25-000060

Insider Transaction Report

Form 4

Period: 2025-05-19

BIOMARIN PHARMACEUTICAL INCBMRN

GVP, Chief Accounting Officer

Transactions

Tax Payment
Common Stock
2025-05-19$59.27/sh−996$59,033→ 15,959 total
Sale
Common Stock
2025-05-20$59.31/sh−1,786$105,928→ 14,173 total

Footnotes (1)

[F1]Trade made pursuant to a 10b5-1 plan executed on November 26, 2024.

Documents

1 file

4
wk-form4_1747778300.xmlPrimary
FORM 4

Issuer

BIOMARIN PHARMACEUTICAL INC

CIK 0001048477

Entity typeother

Related Parties

1

filerCIK 0001927648

Filing Metadata

Form type: 4
Filed: May 19, 8:00 PM ET
Accepted: May 20, 5:58 PM ET
Size: 6.0 KB

View on SEC.gov